Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2026-05-19 @ 9:55 PM
Study NCT ID:
NCT05482893
Status:
RECRUITING
Last Update Posted:
2025-11-04
First Post:
2022-07-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Sponsor:
Organization: